Kamada nets $14.1mm in FOPO

15:40 EDT 1 Aug 2017 | Elsevier Business Intelligence

Kamada Ltd. netted $14.1mm in a follow-on public offering through the sale of 3.3mm shares at $4.50. The company will use the...

Original Article: Kamada nets $14.1mm in FOPO


More From BioPortfolio on "Kamada nets $14.1mm in FOPO"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...